Literature DB >> 10330016

Subtypes of muscarinic receptors regulating gallbladder cholinergic contractions.

H P Parkman1, A P Pagano, J P Ryan.   

Abstract

The aim of this study was to determine the functional role of muscarinic receptor subtypes regulating gallbladder cholinergic contractions. Electrical field stimulation (EFS; 16 Hz) produced contractile responses of guinea pig gallbladder muscle strips in vitro that were inhibited by 1 microM tetrodotoxin (2 +/- 2% of control) and 1 microM atropine (1 +/- 1% of control), indicating activation of intrinsic cholinergic nerves. Exogenous ACh (5 microM)-induced contractions were inhibited by atropine (1 +/- 1% of control) but not tetrodotoxin (102 +/- 1% of control), indicating a direct effect on smooth muscle. The M1 receptor antagonist pirenzepine (10 nM) had no effect on ACh-induced contractions but inhibited EFS-induced contractions by 11 +/- 3%. The M2 antagonist methoctramine (10 nM) had no effect on ACh-induced contractions but augmented EFS-induced contractions by 5 +/- 2%. The M3 antagonist 4-DAMP (10 nM) inhibited ACh-induced contractions by 14 +/- 4% and EFS-induced contractions by 22 +/- 5%. In conclusion, specific M1, M2, and M3 receptors modulate gallbladder muscle contractions by regulating ACh release from cholinergic nerves and mediating the contraction. Cholinergic contractions are mediated by M3 receptors directly on the smooth muscle. M2 receptors are on cholinergic nerves and function as prejunctional inhibitory autoreceptors. M1 receptors are on cholinergic nerves and function as prejunctional facilitatory autoreceptors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10330016     DOI: 10.1152/ajpgi.1999.276.5.G1243

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

1.  Myosin light chain phosphorylation correlates with contractile force in guinea pig gallbladder muscle.

Authors:  H P Parkman; R Garbarino; J P Ryan
Journal:  Dig Dis Sci       Date:  2001-01       Impact factor: 3.199

2.  An electrophysiological study of muscarinic and nicotinic receptors of rat paratracheal ganglion neurons and their inhibition by Z-338.

Authors:  Yumiko Kanemoto; Hitoshi Ishibashi; Atsushi Doi; Norio Akaike; Yushi Ito
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

3.  Nonobese diabetic mice have diminished gallbladder motility and shortened crystal observation time.

Authors:  Shannon J Graewin; James M Kiely; Keun-Ho Lee; Carol L Svatek; Attila Nakeeb; Henry A Pitt
Journal:  J Gastrointest Surg       Date:  2004-11       Impact factor: 3.452

4.  Decreased gallbladder response in leptin-deficient obese mice.

Authors:  Matthew I Goldblatt; Deborah A Swartz-Basile; Carol L Svatek; Atilla Nakeeb; Henry A Pitt
Journal:  J Gastrointest Surg       Date:  2002 May-Jun       Impact factor: 3.452

5.  Mechanisms mediating cholinergic antral circular smooth muscle contraction in rats.

Authors:  Helena-F Wrzos; Tarun Tandon; Ann Ouyang
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

6.  The muscarinic receptor antagonist tropicamide suppresses tremulous jaw movements in a rodent model of parkinsonian tremor: possible role of M4 receptors.

Authors:  Adrienne J Betz; Peter J McLaughlin; Melissa Burgos; Suzanne M Weber; John D Salamone
Journal:  Psychopharmacology (Berl)       Date:  2007-06-27       Impact factor: 4.530

7.  Diminished gallbladder motility in Rotund leptin-resistant obese mice.

Authors:  Shannon J Graewin; Khoi Q Tran; Jurgen K Naggert; Keun-Ho Lee; Debbie Swartz-Basile; Attila Nakeeb; Henry A Pitt
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

8.  Prevention of gallbladder hypomotility via FATP2 inhibition protects from lithogenic diet-induced cholelithiasis.

Authors:  Kevin M Tharp; Amin Khalifeh-Soltani; Hyo Min Park; David A Yurek; Alaric Falcon; Louis Wong; Rouying Feng; Kamran Atabai; Andreas Stahl
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-03-31       Impact factor: 4.052

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.